(Q42996626)

English

Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C.

scientific article published in November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

12 November 2017

author name string

Hagiwara H

1

1 reference

Europe PubMed Central

12 November 2017

Hayashi N

2

1 reference

Europe PubMed Central

12 November 2017

Mita E

3

1 reference

Europe PubMed Central

12 November 2017

Oshita M

4

1 reference

Europe PubMed Central

12 November 2017

Kobayashi I

5

1 reference

Europe PubMed Central

12 November 2017

Iio S

6

1 reference

Europe PubMed Central

12 November 2017

Hiramatsu N

7

1 reference

Europe PubMed Central

12 November 2017

Sasaki Y

8

1 reference

Europe PubMed Central

12 November 2017

Kasahara A

9

1 reference

Europe PubMed Central

12 November 2017

Kakinuma K

10

1 reference

Europe PubMed Central

12 November 2017

Yamauchi T

11

1 reference

Europe PubMed Central

12 November 2017

Fusamoto H

12

1 reference

Europe PubMed Central

12 November 2017

publication date

1 November 1999

1 reference

Europe PubMed Central

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

12 November 2017

6

1 reference

Europe PubMed Central

12 November 2017

6

1 reference

Europe PubMed Central

12 November 2017

463-469

1 reference

Europe PubMed Central

12 November 2017

Isolation of novel virus-like sequences associated with human hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Association between fulminant hepatic failure and a strain of GBV virus C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Histopathologic impact of GB virus C infection on chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Influence of GB virus C viraemia on the clinical, virological and histological features of early hepatitis C-related hepatic disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Detection of a novel DNA virus (TTV) in blood donors and blood products.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Presence of a newly described human DNA virus (TTV) in patients with liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00183.X

21 January 2018

Identifiers

10.1046/J.1365-2893.1999.00183.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42996626&oldid=1592085559"